A carregar...
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
BACKGROUND: Two treatments, ranibizumab and dexamethasone implant, for visual impairment due to macular oedema (ME) secondary to retinal vein occlusion (RVO) have recently been studied in clinical trials. There have been no head to head comparisons of the two treatments, and improvement measured as...
Na minha lista:
| Publicado no: | BMC Med Res Methodol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289570/ https://ncbi.nlm.nih.gov/pubmed/25533265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-14-140 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|